A pituitary adenoma is one of the small lesions every MRI tech and radiology trainee meets early, and the imaging study that confirms it sits at the heart of clinical decisions about hormones, vision and surgery. The sella turcica is tiny, the pituitary stalk is thinner than a pencil lead, and the cavernous sinus packs cranial nerves and a giant artery right next door. Getting the protocol right matters. So does reading the films with a clear mental checklist.
This guide walks through the modern sellar MRI protocol, the imaging signs that separate microadenomas from macroadenomas, and the reporting points that referring endocrinologists and neurosurgeons actually use.
Whether you are sitting for an MRI registry exam, prepping for board review, or auditing your own dictations, the goal is simple. Recognise the lesion, describe it precisely, and never miss the surgical or visual emergency.
The pituitary gland sits in the sella turcica, a bony hammock at the skull base. Above it runs the optic chiasm. Either side, the cavernous sinus carries the internal carotid artery and cranial nerves III, IV, V1, V2 and VI. Below is the sphenoid sinus. That neighbourhood is why we image the gland with thin slices and a small field of view. A routine brain MRI will not cut it.
The gland itself has two parts. The anterior lobe makes growth hormone, prolactin, ACTH, TSH, FSH and LH. The posterior lobe stores vasopressin and oxytocin and shows that classic bright signal on T1 thanks to its lipid-rich neurosecretory granules. When that posterior bright spot is missing, that is a finding in itself.
Adenomas are benign tumours that arise from the anterior lobe. They are graded by size. Microadenomas are less than 10 millimetres. Macroadenomas are 10 millimetres or larger. Giant adenomas are over 40 millimetres.
Most are sporadic, a small share are part of MEN1 or familial syndromes, and prolactinomas are the most common functioning type. Many are picked up because of hormone symptoms. Others appear as incidental findings on scans done for headache or trauma.
The sellar protocol is short but very specific. The reading radiologist needs sub-millimetre information. The technologist needs to plan the coil, the slice angle and the contrast timing carefully. A standard protocol on a 1.5 T or 3 T scanner usually includes a small set of dedicated sequences.
Pre-contrast T1 weighted coronal and sagittal images run at 2 to 3 millimetre slice thickness and no gap. These show the gland margins, the pituitary stalk, and the bright posterior pituitary signal. T2 weighted coronal images at the same resolution give tissue contrast, show cysts, and help separate cystic adenomas from Rathke cleft cysts.
Dynamic contrast-enhanced T1 weighted coronal images come next. These are the workhorse for microadenoma detection. Post-contrast T1 weighted coronal and sagittal images close the sellar block. A whole-brain T1 or FLAIR sequence is added when a macroadenoma is suspected or when symptoms point to a wider problem.
The dynamic sequence is the secret sauce. After a small bolus of gadolinium, the normal pituitary enhances quickly while adenomas enhance more slowly. For about 30 to 90 seconds the adenoma stands out as a relatively hypointense focus against the brightly enhancing gland.
Miss that window and the lesion can blend back in. That is why dynamic imaging is mandatory for any patient with Cushing disease or suspected microprolactinoma.
Normal pituitary tissue enhances faster than adenoma tissue. During the first 30 to 90 seconds after gadolinium injection, microadenomas show up as relatively hypointense focal lesions against the brightly enhancing gland.
Skip the dynamic sequence and a small Cushing-causing adenoma may disappear entirely on delayed images, leading to a false negative report and a missed diagnosis.
Coronal and sagittal, 2-3 mm slices, no gap. Look for the bright posterior pituitary spot, gland contour and any T1 hyperintense blood products.
Tissue contrast for cysts, fluid-fluid levels and Rathke cleft cysts. Compare gland height side to side and check the chiasm.
Rapid coronal T1 sequence covering the gland every few seconds during gadolinium bolus. Workhorse for microadenoma detection.
Coronal and sagittal delayed images. Confirms macroadenoma extent, cavernous sinus invasion and chiasm contact.
Microadenomas usually live entirely within the gland. On unenhanced T1 they tend to be iso to hypointense. On T2 they can be slightly hyperintense. After contrast they enhance later than the normal gland, so they look darker during the dynamic phase and then equalise on delayed images.
Indirect signs help when the lesion is tiny. Look for a focal upward bulge of the gland surface, a deviated pituitary stalk, focal floor depression or remodelling of the sella, and asymmetric height of the two halves of the gland.
Macroadenomas behave differently. They expand the sella, push the gland upward, and often invade or compress the surrounding structures. The classic shape on coronal images is the snowman or figure-of-eight. The waist of the snowman is the diaphragma sellae, which constricts the tumour as it grows.
Above that waist sits the suprasellar component. Below sits the intrasellar bulk. Macroadenomas show a wider range of signal. T1 signal is usually iso to slightly hypointense. T2 signal varies from low to high. Internal cystic change, haemorrhage or necrosis are common in larger tumours, and enhancement is heterogeneous.
The big-ticket questions on every macroadenoma report are simple. Does it touch or compress the optic chiasm. Does it invade the cavernous sinus. Is there evidence of recent bleeding or infarction. Each answer changes management.
Quick MRI literacy is useful for many other neuro topics too. If you want to brush up on basic sequence theory before diving deeper, the MRI basics quiz is a fast way to test yourself.
Less than 10 mm. Intra-glandular. Iso to hypointense on T1. Slightly hyperintense on T2. Delayed enhancement creates a dark focus on the dynamic phase. Indirect signs include focal bulge, stalk deviation, asymmetric gland height and floor remodelling.
10 mm or larger. Expands the sella with snowman or figure-of-eight shape. Variable T1 and T2 signal. Heterogeneous enhancement. Report chiasm contact, cavernous sinus invasion by Knosp grade, sphenoid sinus extension and any haemorrhage.
Sudden headache, vision loss, ophthalmoplegia. Heterogeneous T1 hyperintensity from blood, fluid-fluid levels, peripheral rim enhancement around a necrotic core. SWI helps detect haemorrhage. Treat as an emergency.
Shrinking tumour on dopamine agonists. Post-op sella contains fat, gel foam and air for months. Compare with prior studies. Asymmetric new enhancement in the cavernous sinus is the recurrence flag.
Cavernous sinus invasion changes the surgical plan. Transsphenoidal resection rarely clears tumour that has crossed into the cavernous sinus, so endocrinologists will plan for residual disease and possible radiation. The Knosp grading system, based on coronal images at the level of the carotid artery, helps standardise this judgement.
Grade 0 means the tumour stays medial to a line through the medial carotid margins. Grade 4 means the tumour fully encases the artery. Anything from Grade 3 upward is usually called invasive and predicts incomplete surgical resection.
Chiasm compression is the other big question. The chiasm sits about 5 to 10 millimetres above the diaphragma sellae in most people. On sagittal T2 images, a normal chiasm has a gentle downward curve. A pituitary mass that lifts the chiasm produces an upward bow.
When the chiasm is flattened or stretched, the patient is at risk of bitemporal hemianopia. That is a surgical trigger. Note the contact, the deformation and any T2 signal change within the chiasm itself.
Pituitary apoplexy is haemorrhagic or ischaemic infarction of an adenoma, usually a macroadenoma. It causes sudden headache, vision loss, ophthalmoplegia and sometimes adrenal crisis.
On MRI the signs are dramatic. The tumour shows heterogeneous T1 hyperintensity from blood products, fluid-fluid levels, peripheral enhancement around a necrotic core, and sometimes a swollen, non-enhancing gland. Susceptibility-weighted imaging is helpful when haemorrhage is suspected but the T1 changes are subtle.
This is one of the reads where speed counts. Apoplexy can need same-day surgery and high-dose steroids. A clear, prioritised report saves time. Lead with the diagnosis, then the chiasm, then the cavernous sinus and the carotid arteries.
Several lesions can sit in or above the sella and pretend to be an adenoma. A confident reader keeps the differential short and uses the signal pattern to sort it out.
Craniopharyngiomas often show calcification and cystic spaces with bright T1 fluid. Rathke cleft cysts are smoothly marginated, non-enhancing and often show a small intracystic nodule. Meningiomas of the tuberculum sellae enhance brightly, sit above the diaphragma, and may show a dural tail.
Hypophysitis tends to enlarge the gland symmetrically with a thickened, enhancing stalk and often follows pregnancy or immunotherapy. Empty sella syndrome is the opposite problem. The sella looks expanded but the gland is flattened against the floor and CSF fills the rest of the space.
A normal-functioning gland in an empty sella is usually an incidental finding. A symptomatic patient with hormone deficits needs a careful look for a remnant gland and a check for raised intracranial pressure.
A useful pituitary MRI report is short, specific and structured. Start with size in three dimensions, expressed in millimetres. Describe the location and any extension above the diaphragma sellae, into the cavernous sinus or down into the sphenoid sinus.
Comment on the optic chiasm and stalk position. State whether the carotid arteries are encased and by which Knosp grade. Note any haemorrhage, cystic change or recent infarction. Finish with a short impression that names the most likely diagnosis and points out the surgical or medical implications.
If you are preparing for board-style questions on this exact reporting flow, the sellar protocol guide covers the technical side, while case-based practice locks the patterns into memory.
Treatment changes the imaging pattern. Patients on dopamine agonists for prolactinoma usually show shrinking tumour and progressive fibrosis. After transsphenoidal surgery, the sella often contains fat, gel foam, packing material and air for several months.
That can look complicated, but the question is the same on every follow-up scan. Is there residual or recurrent tumour. Read the dynamic sequence carefully and compare against the most recent prior. Stable post-operative tissue stays the same shape and signal year to year. New growth, especially asymmetric enhancement in the cavernous sinus, is the red flag.
Radiation patients can show progressive empty sella and a thinned stalk. They also have a small risk of radiation-induced meningioma decades later, which is one reason long-term follow-up matters even when hormones are well controlled.
Pituitary MRI looks short and simple, but the room for error is real. A few traps come up again and again on practice tests and in everyday reporting.
Wrong slice angle is the first one. The coronal slab should be perpendicular to the pituitary floor, not to the AC-PC line. Slice angles set for routine brain imaging will blur the gland and hide small lesions. Re-plan the geometry on the sagittal localiser every single time.
Missed dynamic timing is the second. Start contrast injection before the dynamic sequence triggers, not after, or the first-pass enhancement is lost. Saline flush at the same rate keeps the bolus tight. A 1 mL per second injection of 0.1 mmol per kg gadolinium is a typical setting on most systems.
Calling cyst when the lesion is partially thrombosed adenoma is the third. Always check T1 pre-contrast for blood products. A hyperintense rim on pre-contrast T1 means subacute haemorrhage, not simple proteinaceous fluid. The management is completely different.
Forgetting to look at the carotid arteries on every slice is the fourth. Encasement can be subtle on a single image but obvious across the series. Scroll through the coronal post-contrast images and trace the carotid from cavernous segment up to the supraclinoid portion. Any wrap-around above 270 degrees is a red flag.
Cushing disease deserves its own paragraph because the imaging stakes are unusually high. The patient has classic clinical features. Biochemistry confirms ACTH-dependent hypercortisolism. The cure is removal of the ACTH-secreting microadenoma.
For Cushing the protocol must use dedicated dynamic imaging on a 3 T scanner where possible. Spoiled gradient echo or 3D fast spin echo sequences with 1 millimetre slices and high-resolution coronal reformats give the best yield. Even with optimised technique, a normal MRI does not exclude a microadenoma.
Reading these scans is humbling. Subtle gland asymmetry, a faint hypointense focus on a single dynamic phase, or a barely deviated stalk can be the only clue. When the surgeon takes the patient to theatre, your report becomes the road map. Be honest about what you see and what you only suspect.
The normal pituitary enlarges during pregnancy. By the third trimester it can measure up to 12 millimetres in height, with a convex upper border that would look abnormal in any other adult. This is physiological lactotroph hyperplasia, not a macroadenoma.
Imaging is rarely needed in pregnancy unless symptoms point to apoplexy or sudden visual change. Sheehan syndrome is the postpartum complication to remember. Pituitary infarction after major obstetric haemorrhage produces hypopituitarism and an empty sella on later imaging. The acute MRI may show a swollen, non-enhancing gland with peripheral rim enhancement.
Reading pituitary MRI well is about pattern recognition and discipline. Every scan deserves the same checklist, every time. Size first, then chiasm, then cavernous sinus, then haemorrhage, then post-treatment changes. Build the order into your dictation template so nothing gets missed on a busy on-call shift.
For trainees, the fastest way to build that pattern is volume. Look at twenty normals before you tackle ten adenomas, then mix them together. That habit makes borderline cases easier to call. Keep a notebook of the difficult ones with the final pathology or follow-up scan attached. Re-review them at the end of every rotation.
Finally, talk to your endocrinology colleagues. The clinical context they hold often changes how you read the scan. A patient with rising prolactin and a 4 millimetre focus on dynamic imaging is almost certainly a microprolactinoma. The same focus in a hormonally silent patient may be a non-functioning incidentaloma that needs nothing more than a follow-up scan in twelve months.
Multidisciplinary tumour boards are gold for this. When the radiologist, endocrinologist, neurosurgeon and pathologist all sit around the same scan, gaps in the read get spotted fast. Take the opportunity to ask why a particular Knosp call mattered for the surgical plan, or how the pathology lined up with your imaging description. That feedback loop is how good pituitary readers are made.